+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

CRISPR/Cas9 genome editing has provided numerous opportunities to interrogate the functional significance of any given genomic site but one of the major challenges still lies in making the large sized edits of the genome under specific mutations.

Over the years, gene editing has evolved and marked its presence in therapeutics and drug discovery through specific gene targeting and animal modeling based clinical trials.

Having completed two extremely successful editions, 3rd Annual Genome Editing & Engineering Conference taking place on 8th - 9th February 2018 in San Diego, USA once again aims at bringing together the key industry leaders, experts and researchers to address the most recent case studies and research on functional genome screening and precision gene editing to reveal their potential applications.

Post Show Report 2017
Click here to view post-show report of the 2nd Annual Genome Editing & Engineering Conference


conference Registration Form

-


 
  

CategoryCost
Academic Delegate$399
Industry Delegate $549
Solution Provider Delegate$1199

Agenda

Key Highlights

  • In vivo gene delivery
  • Genome wide analysis and interpretation
  • Visualization of genome
  • HDR mediated gene editing
  • TALEN mediated gene knockouts
  • Gene targeting and manipulation
  • RNA nuclease mediated gene editing
  • T-cell adoptive therapy
  • Ethical and regulatory issues
  • Animal modeling based therapeutic applications

To get the agenda copy, kindly email us at amit.shelke@marketsandmarkets.com

Who Should Attend ?

From Pharmaceutical and Bio-pharmaceutical companies:

Senior Scientists/ Principal Scientists/ Project Leaders/Heads in:

  • Genome biology
  • Functional genomics
  • Gene/Cell therapy
  • Genome/Genetic Engineering
  • Genetics
  • Molecular Biology
  • Drug discovery
  • Therapeutics
  • Regenerative medicines
  • Translational sciences
  • Immunology
  • Immuno-oncology

From Universities and Research institutes:

Professors/ Assistant Professors/ Researchers/ Scientists/ Principal Scientists in:

  • Genomic/Genetic Engineering
  • Genetics
  • Functional Genomics
  • Genome Biology
  • Gene Editing/ Genome Editing
  • Molecular Biology
  • Bio-molecular Engineering
  • Bio-chemistry
  • Regenerative medicines
  • Stem cell
  • Gene Therapy/Cell Therapy
  • Immunology
  • Immunotherapy

SPEAKERS

  • Dr. John Feder

    Associate Director, Genome Biology, Bristol-Myers Squibb, NY
  • Dr. Phillippe Duchateau

    Chief Scientific Officer, Cellectis Inc., France
  • Dr. C.B. Gurumurthy

    Director- Mouse Genome Engineering Core Facility, University of Nebraska Medical Center, Nebraska
  • Dr. Jacques P. Tremblay

    Full Professor University of Laval, Canada
  • Dr. Ron Weiss

    Professor, Synthetic Biology Massachusetts Institute of Technology, MA
  • Dr. Shondra Miller

    Director Center of Advanced Genome Engineering, TN
  • Dr. Rob Howes

    Director AstraZeneca, UK
  • Daniel P. Dever

    Instructor Porteus Lab Stanford University Medical Center, CA
  • Dr. John Burnett

    Assistant Professor, Molecular and Cellular Biology City of Hope, CA
  • Dr. Benjamin Kleinstiver

    Instructor Harvard Medical School, MA
  • Dr. Pablo Perez-Pinera

    Assistant Professor University of Illinois, IL
  • Dr. Gene Yao

    Professor University of California San Diego, CA
  • Dr. Prasun Mishra

    Founder & CEO Agility Pharmaceuticals, CA
  • Dr. Eric.B.Kmiec

    Director, Gene Editing Institute, Senior Research Scientist, Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute, DE
  • Dr. Xinxin Wang

    Senior Scientist Poseida Therapeutics, CA
  • Dr. Marco Weinberg

    Head of Molecular Biology Vertex Pharmaceuticals, CA
  • Dr. James E Dahlman

    Assistant Professor Georgia Tech BME Department, GA
  • Kunitoshi Chiba

    Hockemeyer lab, Dept. of Molecular & Cell Biology University of California, Berkeley, CA
  • Dr. Abraham Scaria

    Vice President, Head of Opthalmology Casebia Therapeutics, MA
  • Ben Haley

    Senior Scientist Genentech, CA
  • Annaleen Vermeulen

    Senior Scientist GE Healthcare Dharmacon Inc., CO
  • Paul Diehl

    Chief Operating Officer, Cellecta Inc. CA, USA
  • Xinxin Wang,

    PhD, Senior Scientist, Immuno-Oncology, Poseida Therapeutics, San Diego, CA.
    

SPONSORS


Silver Sponsor
ThermoFisher Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is the world leader in serving science, our mission is to enable researchers to make the world healthier, cleaner and safer.  Through our premier brand –Invitrogen, we offer a wide range of innovative, reliable solutions that are designed to help ensure that the time you invest in your research is efficient, and is rewarded with the reliable results you’re counting on.



Sponsors/Exhibitors

 


 

darmacon sponsor for conferenceDharmacon

Dharmacon revolutionized RNA synthesis in 1995 with the introduction of 2’-ACE synthesis chemistry. Dharmacon made key scientific contributions to the RNA interference field and established market leadership with our siRNA platform. Our CRISPR-Cas9 gene editing products include predesigned genome-wide synthetic and lentiviral guide RNA reagents designed by a validated algorithm, Cas9 nucleases, and design tools & kits for homology-directed repair. We have a well-established history of supporting the global genomics research community and dedication to product innovation.


idt dna sponsors for conferenceIntegrated DNA Technologies 

Integrated DNA Technologies
 
 is the world leader in delivering custom nucleic acid products for the life sciences market in the areas of academic research, medical diagnostics, biotechnology, agriculture, and pharmaceutical development. IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, qPCR, and RNA interference. Through its GMP services, IDT manufactures products used in diagnostic tests for cancer and inherited and infectious diseases.

cellceta sponsors for conferemce Cellecta








 New England Biolabs

For over 40 years, New England Biolabs, Inc. has led the industry in the supply of molecular biology reagents. In addition to products for genomics, NEB continues to expand its offering into areas related to PCR and qPCR, gene expression, sample preparation for next gen sequencing, synthetic biology, glycobiology, genome editing, epigenetics and RNA analysis.



MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 

 


Exhibiting


All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities


  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation/workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on-Meetings


Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty-minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support


MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

For sponsorship opportunities please contact us at events@marketsandmarkets.com

Media partners

SUPPORTING ASSOCIATIONS

BioUtah

BioUtah is an independent, non-profit 501(c)(6) trade association serving Utah's life science industry. Our primary members include organizations focused on research and development, manufacturing and commercialization or provide supportive services to life science technologies and treatments.
Utah’s life science industry consists of a diverse spectrum with strengths in medical device manufacturing and services, research and testing, biotechnology, pharmaceuticals and healthcare IT amongst others; and is a key driver of Utah’s economy.




 California Life Sciences Association (CLSA)

California Life Sciences Association (CLSA) is the leading voice for California’s life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California’s life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state’s most influential life sciences advocacy and business leadership organization.

 


 Colorado BioScience Association

Colorado BioScience Association
 champions life science. The not-for-profit organization represents more than 350 member organizations and serves as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. CBSA grows the bioscience workforce and leads business expansion policies to advance the industry in our state.

To support 3rd Annual Genome Editing & Engineering Conference, please contact Amit at amit.shelke@marketsandmarkets.com

Venue

For more details about the venue, please email us at events@marketsandmarkets.com